Delivery Order SPE2DB20D2001-SPE2DB24FM59J
Award Date
5/1/24
Potential Completion Date
5/2/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of METHOTREXATE 2.5 MG TABLET 100S, a prescription medication, with a ceiling value of $2,542.92 and a performance period ending on June 27, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has a ceiling value of $25,727.25 and an ultimate completion date of December 4, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methotrexate 2.5 mg tablets, a generic prescription medication used to treat various conditions. The award has a ceiling value of $2,490.00 and a completion date of September 18, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.22 Firm Fixed Price contract is for the delivery of 4,560,862,883 units of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Methotrexate 2.5 mg tablets in 100-count bottles, with a ceiling value of $4,588.56 and a completion date of September 3, 2024. The contract is a firm fixed-price delivery order, without any set-aside designation. As a large pharmaceutical supplier to the federal government, AmerisourceBergen has been awarded...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,826.37 firm fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, with a completion date of July 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methotrexate 2.5 mg tablets in units of 20, with a ceiling value of $2,881.43 and a completion date of June 13, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHOTREXATE 2.5 MG TABLET UD 20S, a pharmaceutical product, with a ceiling value of $14,326.92 and a performance period ending on May 19, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside contract. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, through its corporate office division, will provide these pharmaceutical products to support federal healthcare programs and military treatment facilities. This...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8VR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania. The contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions, and has a ceiling value of $3,779.10. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug...